RUA Life Sciences plc (LON:RUA – Get Free Report) shares traded down 9.7% during trading on Tuesday . The company traded as low as GBX 21.08 and last traded at GBX 21.08. 98,450 shares traded hands during mid-day trading, a decline of 63% from the average session volume of 264,659 shares. The stock had previously closed at GBX 23.36.
RUA Life Sciences Stock Performance
The company has a debt-to-equity ratio of 18.95, a quick ratio of 7.32 and a current ratio of 4.64. The stock’s 50-day moving average is GBX 16.55 and its 200 day moving average is GBX 14.33. The firm has a market cap of £13.65 million, a P/E ratio of -2.61 and a beta of 0.97.
RUA Life Sciences Company Profile
The RUA Life Sciences group was created in April 2020 when AorTech International plc acquired RUA Medical Devices Ltd to create a fully formed medical device business. RUA Life Sciences is the holding company of the group trading through four businesses all exploiting the group’s polymer technology. Our vision is to improve the lives of millions of patients by improving and enabling medical devices with Elast-EonTM, the worlds leading long term implantable polyurethane.
Further Reading
- Five stocks we like better than RUA Life Sciences
- Why Applied Optoelectronics Stock May Be Near a Turning Point
- From High-Yield to High-Growth: 3 Stocks Boosting Dividends
- Is Everspin Technologies the Next AI Edge Breakout?
- 5 Robotics Stocks to Watch as Physical AI Builds Momentum
Receive News & Ratings for RUA Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RUA Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
